Page 3 - 90 7 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

It's their job to look at the clinical trial, and a, did it work, and b, were there safety concerns. let's take a look at the efficacy data that these advisers are looking at right now. what pfizer found in a large clinical trial with children ages 5 to 11, the vaccine was 90.7 effective at protecting those children against getting sick from covid-19. what they did is they gave more than 1,300 children in the trial the vaccine. they followed them over time, and only three became sick with covid-19. then they looked at 663 children who got a placebo, a shot of saline that does nothing, and 16 b...

Available data is a nice summary of what the data show. it's important to have this review process, including independent advisory meetings open to the public. i think transparency has been key to public trust. the scientific advisers are debating both the benefits and the risks of vaccination as well as the risks of covid-19 infection in our children. so as a parent, and as pediatrician, the questions that i always ask are, is it safe, is it effective, and will it be impactful in the lives of children. >> your answer to those questions are? >> the -- well, i would say that the independent adv...

Authorization for children age 5s to 11 for pfizer. and then by monday, the fda will have their final decision on emergency use authorization. and then november 2nd and 3rd, next week, cdc advisor, again, external advisers, not a part of the cdc, they'll meet to discuss the specifics of it and whether they'll green light it. after november 3rd, and we think it will be quite soon after 3rd, dr. rochelle walensky, the director of the cdc, would give her thoughts on whether this should be approved the way the fda had laid it out. that's the time line. let's take a look at what the advisers will b...

Age 5 through 11. in just a few hours the advisory committee will vote on the data specifically whether the benefits of vaccinating children outweigh the potential risk. this is the first key meeting in a regulatory process that could finish up as soon as the end of next week and means 28 million children may be able to roll up their sleeves within days. pfizer's involves two shots three weeks apart and each contains one-third of the dose used on adult. a clinical trial of more than 2,000 children voed vaccination 90.7% effective at preventing symptomatic covid-19 and fda suggested it far outw...

An advisory committee is set to meet tomorrow about the pfizer shot for children. pfizer's was 90.7% at preventing covid one week after children got their second shot. an fda analysis found the benefits of vaccinating children clearly outweighed the risks in the majority of scenarios. joining me to talk about this is dr. vin gupta. covid vaccine for kids appear like they're on the horizon. we have an fda vote tomorrow on whether the benefits of the pfizer vaccine outweigh the risk for children. any reason to think this won't get approved or moved to the next step? >> good afternoon, garrett. g...